Mind Medicine (MindMed) Inc.
NASDAQ: MNMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Robert Barrow
- Employees
- 74
- Headquarters
- Vancouver, Canada
- IPO year
- 2016
- Market cap
- $1.6B
- Website
- https://www.mindmed.co
Loading MNMD…
Loading profile data…Frequently asked questions about MNMD
What does Mind Medicine (MindMed) Inc. (MNMD) do?
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments. Among its key pipeline assets is MM-120, currently undergoing Phase 2 clinical trials. This candidate is being investig...
Where does MNMD trade?
Mind Medicine (MindMed) Inc. (MNMD) trades on the NASDAQ Capital Market.
What sector is MNMD in?
Mind Medicine (MindMed) Inc. (MNMD) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Mind Medicine (MindMed) Inc.?
Robert Barrow is the chief executive officer of Mind Medicine (MindMed) Inc. (MNMD).
Where is Mind Medicine (MindMed) Inc. headquartered?
Mind Medicine (MindMed) Inc. is headquartered in Canada.
Does MNMD pay a dividend?
Mind Medicine (MindMed) Inc. (MNMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MNMD go public?
Mind Medicine (MindMed) Inc. (MNMD) completed its initial public offering in 2016.